Search results
Results from the WOW.Com Content Network
A number of other terms have been used to describe the condition and related conditions including: uterine/cervical atresia, traumatic uterine atrophy, sclerotic endometrium, and endometrial sclerosis. [3] There is not any one cause of AS. Risk factors can include myomectomy, cesarean section, infections, age, genital tuberculosis, and obesity ...
Outcomes with treatment are generally good. [4] Rates of endometritis are about 2% following vaginal delivery, 10% following scheduled C-section, and 30% with rupture of membranes before C-section if preventive antibiotics are not used. [5] The term "endomyometritis" may be used when inflammation of the endometrium and the myometrium is present ...
For mild atrophic vaginitis, hyaluronic acid can be used as a treatment first. [31] However, if it is moderate to severe atrophic vaginitis, estrogen therapy is recommended to be used first. [ 31 ] Vitamin E vaginal suppositories were also found to be helpful in relieving symptoms of GSM, but further studies need to be done to evaluate how safe ...
Treatment for endometriosis often includes hormonal therapies, pain management, and in some cases, surgery to remove the endometrial tissue. For women who struggle with infertility due to endometriosis, assisted reproductive technologies such as in vitro fertilization (IVF) may be recommended, sometimes in combination with surgical treatment to ...
Uterine menstrual contractions are caused by prostaglandin, which is produced by normal endometrial tissue. [6] Dysmenorrhea is the main characteristic for this disease which are the result for high prostaglandin levels. Endometrial proliferation is also led by estrogen; some treatments try to reduce its levels in order to decrease symptoms. [6]
After menopause, the lining is often described as being atrophic. In contrast, endometrium that is chronically exposed to estrogens, but not to progesterone, may become hyperplastic. Long-term use of oral contraceptives with highly potent progestins can also induce endometrial atrophy. [13] [14]
The medication poses a risk of endometrial hyperplasia and endometrial cancer in women similarly to other estrogens. [2] [14] As such, it is necessary to combine estetrol with a progestogen in women with intact uteruses to prevent such risks. [15] [14] The safety of estetrol alone in women with an intact uterus is currently being investigated ...
Other treatments target the underlying cause of the hematometra; for example, a hysteroscopy may be required to resect adhesions that have developed following a previous surgery. [1] If the cause of the hematometra is unclear, a biopsy of endometrial tissue can be taken to test for the presence of a neoplasm (cancer). [ 5 ]